232 related articles for article (PubMed ID: 22822047)
1. DPP4 inhibitor vildagliptin preserves β-cell mass through amelioration of endoplasmic reticulum stress in C/EBPB transgenic mice.
Shimizu S; Hosooka T; Matsuda T; Asahara S; Koyanagi-Kimura M; Kanno A; Bartolome A; Etoh H; Fuchita M; Teruyama K; Takahashi H; Inoue H; Mieda Y; Hashimoto N; Seino S; Kido Y
J Mol Endocrinol; 2012 Oct; 49(2):125-35. PubMed ID: 22822047
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in non-obese type 2 diabetic Goto-Kakizaki rats.
Inaba W; Mizukami H; Kamata K; Takahashi K; Tsuboi K; Yagihashi S
Eur J Pharmacol; 2012 Sep; 691(1-3):297-306. PubMed ID: 22820107
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Pancreatic β Cell Mass by Cross-Interaction between CCAAT Enhancer Binding Protein β Induced by Endoplasmic Reticulum Stress and AMP-Activated Protein Kinase Activity.
Matsuda T; Takahashi H; Mieda Y; Shimizu S; Kawamoto T; Matsuura Y; Takai T; Suzuki E; Kanno A; Koyanagi-Kimura M; Asahara S; Bartolome A; Yokoi N; Inoue H; Ogawa W; Seino S; Kido Y
PLoS One; 2015; 10(6):e0130757. PubMed ID: 26091000
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl peptidase-4 inhibitor, vildagliptin, inhibits pancreatic beta cell apoptosis in association with its effects suppressing endoplasmic reticulum stress in db/db mice.
Wu YJ; Guo X; Li CJ; Li DQ; Zhang J; Yang Y; Kong Y; Guo H; Liu DM; Chen LM
Metabolism; 2015 Feb; 64(2):226-35. PubMed ID: 25195070
[TBL] [Abstract][Full Text] [Related]
5. Vildagliptin ameliorates oxidative stress and pancreatic beta cell destruction in type 1 diabetic rats.
Ávila Dde L; Araújo GR; Silva M; Miranda PH; Diniz MF; Pedrosa ML; Silva ME; de Lima WG; Costa DC
Arch Med Res; 2013 Apr; 44(3):194-202. PubMed ID: 23523961
[TBL] [Abstract][Full Text] [Related]
6. Impact of the dipeptidyl peptidase-4 inhibitor vildagliptin on glucose tolerance and β-cell function and mass in insulin receptor substrate-2-knockout mice fed a high-fat diet.
Sato K; Nakamura A; Shirakawa J; Muraoka T; Togashi Y; Shinoda K; Orime K; Kubota N; Kadowaki T; Terauchi Y
Endocrinology; 2012 Mar; 153(3):1093-102. PubMed ID: 22315446
[TBL] [Abstract][Full Text] [Related]
7. Vildagliptin selectively ameliorates GLP-1, GLUT4, SREBP-1c mRNA levels and stimulates β-cell proliferation resulting in improved glucose homeostasis in rats with streptozotocin-induced diabetes.
Akarte AS; Srinivasan BP; Gandhi S
J Diabetes Complications; 2012; 26(4):266-74. PubMed ID: 22626875
[TBL] [Abstract][Full Text] [Related]
8. Vildagliptin preserves the mass and function of pancreatic β cells via the developmental regulation and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.
Hamamoto S; Kanda Y; Shimoda M; Tatsumi F; Kohara K; Tawaramoto K; Hashiramoto M; Kaku K
Diabetes Obes Metab; 2013 Feb; 15(2):153-63. PubMed ID: 22950702
[TBL] [Abstract][Full Text] [Related]
9. Relationships between the islets blood flow, nitric oxide, insulin, and cytosolic calcium in rat pancreatic islets: effects of DPP-IV inhibitor vildagliptin.
Akarte AS; Srinivasan BP; Gandhi S
Eur J Pharm Sci; 2012 Apr; 45(5):546-51. PubMed ID: 22155545
[TBL] [Abstract][Full Text] [Related]
10. GLP-1 signalling compensates for impaired insulin signalling in regulating beta cell proliferation in βIRKO mice.
Kawamori D; Shirakawa J; Liew CW; Hu J; Morioka T; Duttaroy A; Burkey B; Kulkarni RN
Diabetologia; 2017 Aug; 60(8):1442-1453. PubMed ID: 28526921
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of dipeptidyl peptidase-4 by vildagliptin during glucagon-like Peptide 1 infusion increases liver glucose uptake in the conscious dog.
Edgerton DS; Johnson KM; Neal DW; Scott M; Hobbs CH; Zhang X; Duttaroy A; Cherrington AD
Diabetes; 2009 Jan; 58(1):243-9. PubMed ID: 18840785
[TBL] [Abstract][Full Text] [Related]
12. Beta-cell expression of a dominant-negative HNF-1alpha compromises the ability of inhibition of dipeptidyl peptidase-4 to elicit a long-term augmentation of insulin secretion in mice.
Ahrén B; Sörhede Winzell M; Burkey B; Hughes TE
Eur J Pharmacol; 2005 Oct; 521(1-3):164-8. PubMed ID: 16171801
[TBL] [Abstract][Full Text] [Related]
13. The DPP-4 inhibitor vildagliptin increases pancreatic beta cell mass in neonatal rats.
Duttaroy A; Voelker F; Merriam K; Zhang X; Ren X; Subramanian K; Hughes TE; Burkey BF
Eur J Pharmacol; 2011 Jan; 650(2-3):703-7. PubMed ID: 21070766
[TBL] [Abstract][Full Text] [Related]
14. Effects of combination therapy with vildagliptin and valsartan in a mouse model of type 2 diabetes.
Miyagawa K; Kondo T; Goto R; Matsuyama R; Ono K; Kitano S; Kawasaki S; Igata M; Kawashima J; Matsumura T; Motoshima H; Araki E
Cardiovasc Diabetol; 2013 Nov; 12():160. PubMed ID: 24188631
[TBL] [Abstract][Full Text] [Related]
15. Chronic DPP-IV inhibition with PKF-275-055 attenuates inflammation and improves gene expressions responsible for insulin secretion in streptozotocin induced diabetic rats.
Akarte AS; Srinivasan BP; Gandhi S; Sole S
Eur J Pharm Sci; 2012 Sep; 47(2):456-63. PubMed ID: 22800967
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4).
Thornberry NA; Gallwitz B
Best Pract Res Clin Endocrinol Metab; 2009 Aug; 23(4):479-86. PubMed ID: 19748065
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans.
Ahrén B; Schweizer A; Dejager S; Villhauer EB; Dunning BE; Foley JE
Diabetes Obes Metab; 2011 Sep; 13(9):775-83. PubMed ID: 21507182
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase 4 inhibitor reduces intimal hyperplasia in rabbit autologous jugular vein graft under poor distal runoff.
Koyama A; Komori K; Otsuka R; Kajikuri J; Itoh T
J Vasc Surg; 2016 May; 63(5):1360-70. PubMed ID: 25656593
[TBL] [Abstract][Full Text] [Related]
19. Improved meal-related insulin processing contributes to the enhancement of B-cell function by the DPP-4 inhibitor vildagliptin in patients with type 2 diabetes.
Ahrén B; Pacini G; Tura A; Foley JE; Schweizer A
Horm Metab Res; 2007 Nov; 39(11):826-9. PubMed ID: 17992639
[TBL] [Abstract][Full Text] [Related]
20. Liraglutide, but not vildagliptin, restores normoglycaemia and insulin content in the animal model of type 2 diabetes, Psammomys obesus.
Vedtofte L; Bodvarsdottir TB; Gotfredsen CF; Karlsen AE; Knudsen LB; Heller RS
Regul Pept; 2010 Feb; 160(1-3):106-14. PubMed ID: 20005262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
